Institution · Northwest Clinical Research Center

Most cited papers from Northwest Clinical Research Center

Northwest Clinical Research Center

What are the most cited papers from Northwest Clinical Research Center?

The most cited paper from Northwest Clinical Research Center is "The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials" (Jasper Jan Brugts, Tuncay Yetgin, Sanne Elisabeth Hoeks et al., 2009), with 799 citations. Next come "Efficacy of Quetiapine Monotherapy in Bipolar I and II Depression" (560) and "Seizure Incidence in Psychopharmacological Clinical Trials: An Analysis of Food and Drug Administration (FDA) Summary Basis of Approval Reports" (523).

Published TypeFieldAccessCitations

Showing 50 of 60 papers. Every paper with more than 42 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials Jasper Jan Brugts, Tuncay Yetgin, Sanne Elisabeth Hoeks et al. · BMJ ReviewOpen access	30 Jun 2009	799
2	Efficacy of Quetiapine Monotherapy in Bipolar I and II Depression Michael E. Thase, Wayne Macfadden, Richard H. Weisler et al. · Journal of Clinical Psychopharmacology	18 Nov 2006	560
3	Seizure Incidence in Psychopharmacological Clinical Trials: An Analysis of Food and Drug Administration (FDA) Summary Basis of Approval Reports Kenneth Alper, Kelly A. Schwartz, Russell L. Kolts et al. · Biological Psychiatry	17 Jan 2007	523
4	Symptom Reduction and Suicide Risk in Patients Treated With Placebo in Antidepressant Clinical Trials Arif Khan, Heather Warner, Walter A. Brown · Archives of General Psychiatry	Apr 2000	480
5	Severity of Depression and Response to Antidepressants and Placebo: An Analysis of the Food and Drug Administration Database Arif Khan, Robyn M. Leventhal, Shirin Khan et al. · Journal of Clinical Psychopharmacology	Feb 2002	462
6	Suicide Rates in Clinical Trials of SSRIs, Other Antidepressants, and Placebo: Analysis of FDA Reports Arif Khan, Shirin Khan, Russell L. Kolts et al. · American Journal of Psychiatry	31 Mar 2003	397
7	Trends in Incidence of Type 1 and Type 2 Diabetes Among Youths — Selected Counties and Indian Reservations, United States, 2002–2015 Jasmin Divers, Elizabeth J. Mayer‐Davis, Jean M. Lawrence et al. · MMWR Morbidity and Mortality Weekly Report Open access	13 Feb 2020	379
8	Management of the Potential Organ Donor in the ICU Robert M. Kotloff et al. · Critical Care Medicine	16 May 2015	375
9	α-Catenin Is a Tumor Suppressor That Controls Cell Accumulation by Regulating the Localization and Activity of the Transcriptional Coactivator Yap1 Mark R. Silvis, Bridget T. Kreger, Wen‐Hui Lien et al. · Science Signaling Open access	24 May 2011	346
10	A Systematic Review of Comparative Efficacy of Treatments and Controls for Depression Arif Khan, James Faucett, Pesach Lichtenberg et al. · PLoS ONE ReviewOpen access	30 Jul 2012	291
11	Sex Differences in Antidepressant Response in Recent Antidepressant Clinical Trials Arif Khan, Amy E. Brodhead, Kelly A. Schwartz et al. · Journal of Clinical Psychopharmacology	12 Jul 2005	253
12	Aripiprazole Monotherapy in Nonpsychotic Bipolar I Depression Michael E. Thase, Alan Jonas, Arif Khan et al. · Journal of Clinical Psychopharmacology	Feb 2008	252
13	Antidepressants versus placebo in major depression: an overview Arif Khan, Walter A. Brown · World Psychiatry Open access	25 Sep 2015	239
14	Suicide risk in patients with anxiety disorders: a meta-analysis of the FDA database Arif Khan, Robyn M. Leventhal, Shirin Khan et al. · Journal of Affective Disorders Review	Apr 2002	190
15	Relative sensitivity of the Montgomery-Asberg Depression Rating Scale, the Hamilton Depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials A Khan, Shirin Khan, E.B. Shankles et al. · International Clinical Psychopharmacology	Nov 2002	163
16	Mifepristone versus Placebo in the Treatment of Psychosis in Patients with Psychotic Major Depression Charles DeBattista, Joseph K. Belanoff, Steven Glass et al. · Biological Psychiatry	7 Aug 2006	162
17	Frequency of Positive Studies Among Fixed and Flexible Dose Antidepressant Clinical Trials: An Analysis of the Food and Drug Administraton Summary Basis of Approval Reports Arif Khan, Shirin Khan, Gary Walens et al. · Neuropsychopharmacology Open access	16 Sep 2002	159
18	Placebo Response and Antidepressant Clinical Trial Outcome Arif Khan, Michael J. Detke, Shirin Khan et al. · The Journal of Nervous and Mental Disease	Apr 2003	155
19	Adherence to asthma controller medication regimens David A. Stempel, Stuart W. Stoloff, Jacqueline R. Carranza Rosenzweig et al. · Respiratory Medicine Open access	13 Apr 2005	144
20	Are placebo controls necessary to test new antidepressants and anxiolytics? Arif Khan, Shirin Khan, Walter A. Brown · The International Journal of Neuropsychopharmacology	Sep 2002	131
21	A Randomized, Double-Blind, Placebo-Controlled, 8-Week Study of Vilazodone, a Serotonergic Agent for the Treatment of Major Depressive Disorder Arif Khan, Andrew J. Cutler, Daniel K. Kajdasz et al. · The Journal of Clinical Psychiatry	15 Apr 2011	131
22	Symptom Reduction and Suicide Risk Among Patients Treated With Placebo in Antipsychotic Clinical Trials: An Analysis of the Food and Drug Administration Database Arif Khan, Shirin Khan, Robyn M. Leventhal et al. · American Journal of Psychiatry	Sep 2001	131
23	Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study Ronald N. Marcus, Arif Khan, Linda Rollin et al. · Bipolar Disorders	Mar 2011	130
24	Magnitude of placebo response and drug–placebo differences across psychiatric disorders Arif Khan, Russell L. Kolts, Mark Hyman Rapaport et al. · Psychological Medicine	12 Nov 2004	122
25	Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study Gerard Sanacora, Michael R. Johnson, Arif Khan et al. · Neuropsychopharmacology Open access	29 Sep 2016	118
26	Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials Arif Khan, Amy E. Brodhead, Russell L. Kolts et al. · Journal of Psychiatric Research	28 Sep 2004	116
27	Has the rising placebo response impacted antidepressant clinical trial outcome? Data from the US Food and Drug Administration 1987‐2013 Arif Khan, Kaysee Fahl Mar, Jim Faucett et al. · World Psychiatry Open access	12 May 2017	111
28	Declining Insulin Requirement in the Late First Trimester of Diabetic Pregnancy Lois G. Jovanovic, Robert H. Knopp, Zane A. Brown et al. · Diabetes Care Open access	Jul 2001	110
29	Comparative Mortality Risk in Adult Patients With Schizophrenia, Depression, Bipolar Disorder, Anxiety Disorders, and Attention-Deficit/Hyperactivity Disorder Participating in Psychopharmacology Clinical Trials Arif Khan, James Faucett, Shaneta Morrison et al. · JAMA Psychiatry	28 Aug 2013	109
30	Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database Arif Khan, Shirin R. Khan, Robyn M. Leventhal et al. · The International Journal of Neuropsychopharmacology Open access	Jun 2001	100
31	A Double-Blind, Placebo-Controlled Study of a Flexible Dose of Venlafaxine ER in Adult Outpatients With Generalized Social Anxiety Disorder Karl Rickels, Richard M. Mangano, Arifulla Khan · Journal of Clinical Psychopharmacology	7 Sep 2004	96
32	Research Design Features and Patient Characteristics Associated With the Outcome of Antidepressant Clinical Trials Arif Khan, Russell L. Kolts, Michael E. Thase et al. · American Journal of Psychiatry	28 Oct 2004	94
33	Double-Blind Comparison of Escitalopram and Duloxetine in??the??Acute Treatment of Major??Depressive Disorder Arif Khan, Anjana Bose, George S. Alexopoulos et al. · Clinical Drug Investigation	2007	93
34	Cardiovascular effects of endogenous and exogenous sex hormones over a woman's lifetime Robert H. Knopp · American Journal of Obstetrics and Gynecology	Jun 1988	92
35	Metabolism of very-low-density lipoprotein triglyceride by human placental cells: The role of lipoprotein lipase Bartolomé Bonet, John D. Brunzell, Allen M. Gown et al. · Metabolism	Jun 1992	91
36	Report of National Kidney Foundation Consensus Conference to Decrease Kidney Discards MATTHEW M. COOPER, Richard N. Formica, John J. Friedewald et al. · Clinical Transplantation	21 Oct 2018	85
37	Use of Buspirone in Patients with Generalized Anxiety Disorder and Coexisting Depressive Symptoms Richard E. Gammans, Joseph Stringfellow, A.J. Hvizdos et al. · Neuropsychobiology	21 Feb 2008	84
38	Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain Martin E Hale, Arif Khan, M. Kutch et al. · Current Medical Research and Opinion	30 Apr 2010	82
39	One-Year Effects of Increasingly Fat-Restricted, Carbohydrate-Enriched Diets on Lipoprotein Levels in Free-Living Subjects Robert H. Knopp, Barbara M. Retzlaff, Carolyn E. Walden et al. · Proceedings of The Society for Experimental Biology and Medicine	Dec 2000	80
40	Why Has the Antidepressant–Placebo Difference in Antidepressant Clinical Trials Diminished over the Past Three Decades? Arif Khan, Amritha S Bhat, Russell L. Kolts et al. · CNS Neuroscience & Therapeutics Open access	Jul 2010	79
41	Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder Maju Mathews, Carl Gommoll, Dalei Chen et al. · International Clinical Psychopharmacology Open access	14 Dec 2014	77
42	Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study David Bakish, Anjana Bose, Carl Gommoll et al. · Journal of Psychiatry and Neuroscience Open access	2014	70
43	The persistence of the placebo response in antidepressant clinical trials Arif Khan, Nick Redding, Walter A. Brown · Journal of Psychiatric Research	Dec 2007	69
44	Measurements of Ti3+:Al2O3 as a lasing material G. Albrecht, John M. Eggleston, James J. Ewing · Optics Communications	1985	67
45	A Randomized, Double-Blind Study of Once-Daily Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients With Generalized Anxiety Disorder Arifulla Khan, Mark A. Joyce, Sarah D. Atkinson et al. · Journal of Clinical Psychopharmacology	21 Jun 2011	66
46	Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study Gary S. Sachs, Paul P. Yeung, Ludmyla Rekeda et al. · American Journal of Psychiatry Open access	15 Feb 2023	62
47	Testosterone enanthate at a dose of 200 mg/week decreases HDL‐cholesterol levels in healthy men Maria Cristina Meriggiola, Santica M. Marcovina, C. Alvin Paulsen et al. · International Journal of Andrology	Oct 1995	62
48	Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression Arif Khan · Expert Opinion on Investigational Drugs	21 Sep 2009	62
49	BMI, sex, and antidepressant response Arif Khan, Kelly A. Schwartz, Russell L. Kolts et al. · Journal of Affective Disorders	28 Sep 2006	61
50	Treatment with Venlafaxine Extended Release After SSRI Nonresponse or Intolerance Michael E. Thase, Richard C. Shelton, Arifulla Khan · Journal of Clinical Psychopharmacology	9 May 2006	59

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.